Literature DB >> 6938516

Variation in steroid 5 alpha-reductase activity in cloned human skin fibroblasts. Shift in phenotypic expression from high to low activity upon subcloning.

J E Griffin, D R Allman, J L Durrant, J D Wilson.   

Abstract

Steroid 5 alpha-reductase in skin fibroblasts varies in two ways: 1) mean activity in uncloned fibroblasts corresponds to the activity in skin from which fibroblasts are derived (high in genital skin and low in nongenital skin); 2) activity in normal genital skin fibroblasts varies over a wide range (more than 200-fold). Studies of activity in fibroblast clones provides an explanation for this variability. Activity in clones of genital skin fibroblasts varies from the limits of detectability to very high levels, whereas activity in fibroblasts cloned from nongenital skin is uniformly low. The mean value of 5 alpha-reductase in genital skin clones is similar to the value in uncloned fibroblasts from the same explant. This suggests that the numbers of high and low activity cells in a given explant influence the overall enzyme activity. Variability among normal genital skin strains is also due to inherent differences in the range of enzyme activities. Furthermore, high activity genital skin clones give rise to a mixture of both high and low-activity subclones, whereas low activity genital skin and nongenital skin clones give rise to populations with uniformly low activity. Thus, with time genital skin gives rise to high activity fibroblasts that continually undergo shift in phenotypic expression to low activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6938516

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  The significance of biological heterogeneity.

Authors:  H Rubin
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

2.  Vaginal and uterine stroma maintain their inductive properties following primary culture.

Authors:  P S Cooke; D K Fujii; G R Cunha
Journal:  In Vitro Cell Dev Biol       Date:  1987-03

Review 3.  Implications of tumor progression on clinical oncology.

Authors:  D R Welch; S P Tomasovic
Journal:  Clin Exp Metastasis       Date:  1985 Jul-Sep       Impact factor: 5.150

4.  Tumor heterogeneity: biological implications and therapeutic consequences.

Authors:  G H Heppner; B E Miller
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  Tumor progression, oncogenes and the evolution of metastatic phenotypic diversity.

Authors:  G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

6.  Expression of a mutant androgen receptor in cloned fibroblasts derived from a heterozygous carrier for the syndrome of testicular feminization.

Authors:  M K Elawady; D R Allman; J E Griffin; J D Wilson
Journal:  Am J Hum Genet       Date:  1983-05       Impact factor: 11.025

Review 7.  Generation of phenotypic diversity and progression in metastatic tumor cells.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

8.  Influence of anatomic site and age on the replication and differentiation of rat adipocyte precursors in culture.

Authors:  P Djian; A K Roncari; C H Hollenberg
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

9.  Early origin and pervasiveness of cellular heterogeneity in some malignant transformations.

Authors:  H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  Intraclonal protein expression heterogeneity in recombinant CHO cells.

Authors:  Warren Pilbrough; Trent P Munro; Peter Gray
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.